Hepatocellular carcinoma tumour burden score to stratify prognosis after resection

被引:104
|
作者
Tsilimigras, D. I. [1 ]
Moris, D. [1 ]
Hyer, J. M. [1 ]
Bagante, F. [1 ,4 ]
Sahara, K. [1 ]
Moro, A. [1 ]
Paredes, A. Z. [1 ]
Mehta, R. [1 ]
Ratti, F. [5 ]
Marques, H. P. [6 ]
Silva, S. [6 ]
Soubrane, O. [7 ]
Lam, V. [8 ]
Poultsides, G. A. [3 ]
Popescu, I. [10 ]
Alexandrescu, S. [10 ]
Martel, G. [11 ]
Workneh, A. [11 ]
Guglielmi, A. [4 ]
Hugh, T. [9 ]
Aldrighetti, L. [5 ]
Endo, I. [12 ]
Sasaki, K. [2 ]
Rodarte, A. [2 ]
Aucejo, F. N. [2 ]
Pawlik, T. M. [1 ]
机构
[1] Ohio State Univ, Dept Surg, Wexner Med Ctr, 395 W 12th Ave,Suite 670, Columbus, OH 43210 USA
[2] Cleveland Clin, Digest Dis Inst, Cleveland, OH 44106 USA
[3] Stanford Univ, Stanford, CA 94305 USA
[4] Univ Verona, Dept Surg, Verona, Italy
[5] Osped San Raffaele, Milan, Italy
[6] Curry Cabral Hosp, Dept Surg, Lisbon, Portugal
[7] Beaujon Hosp, AP HP, Dept Hepatobiliopancreat Surg, Clichy, France
[8] Westmead Hosp, Dept Surg, Sydney, NSW, Australia
[9] Univ Sydney, Sch Med, Sydney, NSW, Australia
[10] Fundeni Clin Inst, Dept Surg, Bucharest, Romania
[11] Univ Ottawa, Dept Surg, Ottawa, ON, Canada
[12] Yokohama City Univ, Sch Med, Yokohama, Kanagawa, Japan
关键词
SURGICAL RESECTION; LIVER RESECTION; GUIDELINES; SURVIVAL; SELECTION; INVASION; SURGERY; SIZE; TOOL; HCC;
D O I
10.1002/bjs.11464
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background Although the Barcelona Clinic Liver Cancer (BCLC) staging system has been largely adopted in clinical practice, recent studies have emphasized the need for further refinement and subclassification of this system. Methods Patients who underwent hepatectomy with curative intent for BCLC-0, -A or -B hepatocellular carcinoma (HCC) between 2000 and 2017 were identified using a multi-institutional database. The tumour burden score (TBS) was calculated, and overall survival (OS) was examined in relation to TBS and BCLC stage. Results Among 1053 patients, 63 (6 center dot 0 per cent) had BCLC-0, 826 (78 center dot 4 per cent) BCLC-A and 164 (15 center dot 6 per cent) had BCLC-B HCC. OS worsened incrementally with higher TBS (5-year OS 77 center dot 9, 61 and 39 per cent for low, medium and high TBS respectively; P < 0 center dot 001). No differences in OS were noted among patients with similar TBS, irrespective of BCLC stage (61 center dot 6 versus 58 center dot 9 per cent for BCLC-A/medium TBS versus BCLC-B/medium TBS, P = 0 center dot 930; 45 versus 13 per cent for BCLC-A/high TBS versus BCLC-B/high TBS, P = 0 center dot 175). Patients with BCLC-B HCC and a medium TBS had better OS than those with BCLC-A disease and a high TBS (58 center dot 9 versus 45 per cent; P = 0 center dot 005). On multivariable analysis, TBS remained associated with OS among patients with BCLC-A (medium TBS: hazard ratio (HR) 2 center dot 07, 95 per cent c.i. 1 center dot 42 to 3 center dot 02, P < 0 center dot 001; high TBS: HR 4 center dot 05, 2 center dot 40 to 6 center dot 82, P < 0 center dot 001) and BCLC-B (high TBS: HR 3 center dot 85, 2 center dot 03 to 7 center dot 30; P < 0 center dot 001) HCC. TBS could also stratify prognosis among patients in an external validation cohort (5-year OS 79, 51 center dot 2 and 28 per cent for low, medium and high TBS respectively; P = 0 center dot 010). Conclusion The prognosis of patients with HCC varied according to the BCLC stage but was largely dependent on the TBS.
引用
收藏
页码:854 / 864
页数:11
相关论文
共 50 条
  • [21] The impact of esophageal varices on the prognosis of patients with hepatocellular carcinoma after surgical resection: a propensity score matching analysis
    Chang, C. -Y.
    Su, C. -W.
    Hsieh, W. -Y.
    Chau, G. -Y.
    Hou, M. -C.
    Chen, P. -H.
    Lee, P. -C.
    Huo, T. -I.
    Huang, Y. -H.
    Lin, H. -C.
    Wu, J. -C.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S138 - S139
  • [22] Tumor burden score-AFP-albumin-bilirubin grade score predicts the survival of patients with hepatocellular carcinoma after liver resection
    Zhan-Cheng Qiu
    Chuan Li
    Yu Zhang
    Fei Xie
    Yu Yu
    Shu-Sheng Leng
    Ting-Hao Chen
    Tian-Fu Wen
    Langenbeck's Archives of Surgery, 408
  • [23] Tumor burden score-AFP-albumin-bilirubin grade score predicts the survival of patients with hepatocellular carcinoma after liver resection
    Qiu, Zhan-Cheng
    Li, Chuan
    Zhang, Yu
    Xie, Fei
    Yu, Yu
    Leng, Shu-Sheng
    Chen, Ting-Hao
    Wen, Tian-Fu
    LANGENBECKS ARCHIVES OF SURGERY, 2023, 408 (01)
  • [24] Erratum to: Glasgow Prognostic Score and Prognosis After Hepatectomy for Hepatocellular Carcinoma
    Tomoyuki Abe
    Hirotaka Tashiro
    Tsuyoshi Kobayashi
    Minoru Hattori
    Shintaro Kuroda
    Hideki Ohdan
    World Journal of Surgery, 2017, 41 : 1857 - 1859
  • [25] HIWI is associated with prognosis in patients with hepatocellular carcinoma after curative resection
    Zhao, Yi-Ming
    Zhou, Jia-Min
    Wang, Long-Rong
    He, Hong-Wei
    Wang, Xi-Long
    Tao, Zhong-Hua
    Sun, Hui-Chuan
    Wu, Wei-Zhong
    Fan, Jia
    Tang, Zhao-You
    Wang, Lu
    CANCER, 2012, 118 (10) : 2708 - 2717
  • [26] Combined Hepatocellular Carcinoma and Cholangiocarcinoma: Diagnosis and Prognosis After Resection or Transplantation
    Wu, C. -H.
    Yong, C-C.
    Liew, E. -H.
    Tsang, L. L. -C.
    Lazo, M.
    Hsu, H. -W.
    Ou, H. -Y.
    Yu, C. -Y.
    Chen, T. -Y.
    Huang, T. -L.
    Concejero, A. M.
    Chen, C. -L.
    Cheng, Y. -F.
    TRANSPLANTATION PROCEEDINGS, 2016, 48 (04) : 1100 - 1104
  • [27] Role of Lipids and Apolipoproteins in Predicting the Prognosis of Hepatocellular Carcinoma After Resection
    Ni, Xiao-Chun
    Yi, Yong
    Fu, Yi-Peng
    Cai, Xiao-Yan
    Liu, Gao
    Huang, Jin-Long
    Gan, Wei
    Xu, Jie
    Qiu, Shuang-Jian
    ONCOTARGETS AND THERAPY, 2020, 13 : 12867 - 12880
  • [28] Long-term prognosis after resection of cryptogenic hepatocellular carcinoma
    Yu Ohkura
    Kazunari Sasaki
    Masamichi Matsuda
    Masaji Hashimoto
    Goro Watanabe
    BMC Surgery, 15
  • [29] Reply to: IL-26 and the prognosis of hepatocellular carcinoma after resection
    Xi, Zhi-Feng
    Jeong, Seogsong
    Xia, Qiang
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2019, 18 (05) : 502 - 502
  • [30] Letter: sex disparity in prognosis of patients with hepatocellular carcinoma after resection
    Deng, Zhu-Jian
    Liu, Hao-Tian
    Gong, Wen-Feng
    Xiang, Bang-De
    Zhong, Jian-Hong
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2020, 52 (11-12) : 1767 - 1768